Shares of Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) traded up 2.9% during mid-day trading on Wednesday . The stock traded as high as $1.44 and last traded at $1.44. 171,960 shares changed hands during trading, an increase of 156% from the average session volume of 67,097 shares. The stock had previously closed at $1.40.
Cardiol Therapeutics Stock Performance
The company has a 50-day moving average of $1.33 and a 200-day moving average of $1.21.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
Read More
- Five stocks we like better than Cardiol Therapeutics
- What is Short Interest? How to Use It
- Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- How Marvell Went From Short Target to Breakout Star
- Breakout Stocks: What They Are and How to Identify Them
- Palo Alto Networks: The All‑in‑One Cybersecurity Powerhouse
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
